Oric Pharmaceuticals, Inc. Common Stock

ORIC XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

1.3B

Short interest (Jun 15)

20.3%

Borrow Fee

0.39%

↑ 14.0%

Available Shares

↑ 190.0%

Price Chart

Company Overview

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001796280

Asset Type: CS

Market Data

Market Cap: $1,252,562,500

Employees: 104

Status: Active

Short Interest

Current Borrow Fee 0.39%

Range: 0.39% - 0.39%

Available Shares 1M

Range: 450K - 1.1M

Recent Changes

Fee Change: ↓ 21.0%

Available Change: ↓ 8.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime